According to a recent study by Future Market Insights, Inc, the global market for companion animal vaccines is projected to experience a significant growth rate of 6.8% CAGR from 2023 to 2033. This burgeoning sector, valued at US$ 3.4 billion as of 2023, is forecasted to more than double, surpassing US$ 6.7 billion by the end of the forecast period in 2033.
This substantial growth can be attributed to several key factors including the increasing humanization of pets, a rise in awareness about pet insurance, and an escalation in the prevalence of animal diseases. These elements are driving pet owners and veterinarians towards more rigorous vaccination protocols, which have already successfully eradicated many chronic diseases in companion animals across developed nations.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1427
Moreover, the veterinary healthcare sector is experiencing a heightened demand for vaccines, especially protozoan parasitic vaccines, particularly in tropical and subtropical regions where such parasites are more prevalent. The industry’s pivot from traditional chemotherapeutic agents to vaccines is further fueled by the development of resistance against many anti-parasitic drugs.
In response to these challenges, the scientific community has been actively engaged in the development of third-generation DNA vaccines targeted at combating protozoan parasites. These advanced vaccines are heralded for their safety, as they do not contain live pathogens, and are also noted for their stability and cost-effectiveness compared to live attenuated and killed virus vaccines.
As the market continues to expand, the focus on innovative vaccine solutions and comprehensive vaccination campaigns is expected to remain a cornerstone of global efforts in improving companion animal health and preventing the spread of potentially debilitating diseases.
The passage outlines two main restraining factors for the companion animal vaccines market:
Shift in Sales Channels:
- The Fairness to Pet Owners Act allows pet owners to purchase vaccines from retailers and pharmacies, bypassing veterinarians.
- This reduces the market share traditionally held by veterinarians and forces vaccine companies to adapt their sales strategies.
- The shift might also affect profit margins due to changes in distribution channels and consolidation of veterinary clinics.
Knowledge Gaps in Disease Epidemiology:
- Lack of understanding about the prevalence and spread of veterinary diseases, particularly in endemic countries, hinders vaccine development.
- The example of Newcastle Disease in poultry highlights this issue.
- Rapid mutations and variations in the virus make it difficult to develop effective vaccines, limiting the market potential.
Methodology Details Just a Click Away: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1427
Competition Analysis:
- Bayer Healthcare
- Vétoquinol S.A
- Boehringer Ingelheim
- Ceva Santé Animale
- Eli Lilly and Company
- Heska Corp.
- Merck Animal Health
- Sanofi
- Virbac
- Pfizer
Companion Animal Vaccines Market Segmentation
By Product Type:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Species Types:
- Canine
- Avian
- Feline
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Request Purchase on Report: https://www.futuremarketinsights.com/checkout/1427
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
